Adaptimmune Therapeutics
ADAP
#8447
Rank
HK$1.20 B
Marketcap
HK$4.70
Share price
0.82%
Change (1 day)
20.41%
Change (1 year)

Market capitalization of Adaptimmune Therapeutics (ADAP)

Market cap: HK$1.20 Billion

As of December 2024 Adaptimmune Therapeutics has a market cap of HK$1.20 Billion. This makes Adaptimmune Therapeutics the world's 8447th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Adaptimmune Therapeutics from 2015 to 2024

End of year Market Cap

Year Marketcap Change
2024HK$1.20 B-14.47%
2023HK$1.40 B-24.73%
2022HK$1.86 B-59.08%
2021HK$4.56 B-29.38%
2020HK$6.46 B558.07%
2019HK$0.98 B-79.13%
2018HK$4.70 B-3.7%
2017HK$4.88 B119.94%
2016HK$2.22 B-66.4%
2015HK$6.61 B

End of Day market cap according to different sources

On Dec 22nd, 2024 the market cap of Adaptimmune Therapeutics was reported to be:

HK$1.20 Billion
by Nasdaq info icon info icon
HK$1.20 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
HK$10.83 B 800.36%๐Ÿ‡บ๐Ÿ‡ธ USA
HK$0.30 B-74.26%๐Ÿ‡บ๐Ÿ‡ธ USA
HK$6.43 B 434.72%๐Ÿ‡ณ๐Ÿ‡ฑ Netherlands
HK$73.89 B 6,042.07%๐Ÿ‡บ๐Ÿ‡ธ USA